<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="mig01/PMC7039625/results/search/migration/results.xml">
  <result pre="to identify whether the overexpression of TRPV1 can affect the" exact="migration" post="of VSMCs in response to AngII. The result showed"/>
  <result pre="AngII. The result showed that in VSMCs infused by AngII," exact="migration" post="was increased while it can be attenuated by overexpression"/>
  <result pre="by overexpression of TRPV1 and down-regulation of TRPV1 promoted the" exact="migration" post="(Figure 5). Figure 1. ApoE−/- mice were infused with"/>
  <result pre="&amp;lt; 0.01 vs. saline group. Figure 5. TRPV1 overexpression inhibits" exact="migration" post="and down-regulation of TRPV1 promotes the migration of VSMCs"/>
  <result pre="TRPV1 overexpression inhibits migration and down-regulation of TRPV1 promotes the" exact="migration" post="of VSMCs infused with AngII. Representative images show cultured"/>
  <result pre="down-regulated SM22α and α-SMA caused by AngII infusion. Meanwhile, the" exact="migration" post="of VSMCs induced by AngII was also converted by"/>
  <result pre="in AAA formation. Maegdefessel L et al. reported that the" exact="migration" post="of VSMCs was increased in both human specimens and"/>
  <result pre="human specimens and animal models of AAA and inhibition of" exact="migration" post="may attenuate AAA[35]. Our study verified that the hypothesis"/>
  <result pre="attenuate AAA[35]. Our study verified that the hypothesis and the" exact="migration" post="of VSMCs induced by AngII infusion could be inhibited"/>
  <result pre="&amp;lt; 0.01 was considered statistically significant. Disclosure statement No potential" exact="conflict" post="of interest was reported by the authors. Supplementary material"/>
 </snippets>
</snippetsTree>
